ResearchTrend.AI
  • Papers
  • Communities
  • Events
  • Blog
  • Pricing
Papers
Communities
Social Events
Terms and Conditions
Pricing
Parameter LabParameter LabTwitterGitHubLinkedInBlueskyYoutube

© 2025 ResearchTrend.AI, All rights reserved.

  1. Home
  2. Papers
  3. 1703.10651
98
8
v1v2v3v4 (latest)

Reliable Decision Support using Counterfactual Models

30 March 2017
Peter F. Schulam
Suchi Saria
    CMLOffRLOOD
ArXiv (abs)PDFHTML
Abstract

Making a good decision involves considering the likely outcomes under each possible action. For example, would drug A or drug B lead to a better outcome for this patient? Ideally, we answer these questions using an experiment, but this is not always possible (e.g., it may be unethical). As an alternative, we can use non-experimental data to learn models that make counterfactual predictions of what we would observe had we run an experiment. To learn such models for decision-making problems, we propose the use of counterfactual objectives in lieu of classical supervised learning objectives. We implement this idea in a challenging and frequently occurring context, and propose the counterfactual GP (CGP), a counterfactual model of continuous-time trajectories (time series) under sequences of actions taken in continuous-time. We develop our model within the potential outcomes framework of Neyman and Rubin. The counterfactual GP is trained using a joint maximum likelihood objective that adjusts for dependencies between observed actions and outcomes in the training data. We report two sets of experimental results. First, we show that the CGP's predictions are reliable; they are stable to changes in certain characteristics of the training data that are not relevant to the decision-making problem. Predictive models trained using classical supervised learning objectives, however, are not stable to such perturbations. In the second experiment, we use data from a real intensive care unit (ICU) and qualitatively demonstrate how the CGP's ability to answer "What if?" questions offers medical decision-makers a powerful new tool for planning treatment.

View on arXiv
Comments on this paper